UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study

The lancet oncology, 2016-08, Vol.17 (8), p.1158-1170

2016

Volltextzugriff (PDF)

Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017

International journal of cancer, 2021-05, Vol.148 (9), p.2289-2303

2021

Volltextzugriff (PDF)

Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes

Breast cancer research : BCR, 2019-08, Vol.21 (1), p.90-90, Article 90

2019

Volltextzugriff (PDF)

Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?

Nature reviews. Clinical oncology, 2015-10, Vol.12 (10), p.597-606

2015

Volltextzugriff (PDF)

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging

Human brain mapping, 2012-12, Vol.33 (12), p.2971-2983

2012

Volltextzugriff (PDF)

Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy?

Nature reviews. Clinical oncology, 2012-09, Vol.9 (9), p.529-541

2012

Volltextzugriff (PDF)

High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: a discrete choice experiment among healthcare providers

Acta oncologica, 2024-09, Vol.63 (1), p.701-709

2024

Volltextzugriff (PDF)

Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial

Journal of clinical oncology, 2010-03, Vol.28 (8), p.1294-1300

2010

Volltextzugriff (PDF)

Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen

Clinical pharmacokinetics, 2015-08, Vol.54 (8), p.797-810

2015

Volltextzugriff (PDF)

Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model

Cancer cell, 2003-09, Vol.4 (3), p.181-189

2003

Volltextzugriff (PDF)

Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer

Nature communications, 2018-02, Vol.9 (1), p.482-12, Article 482

2018

Volltextzugriff (PDF)

Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years

European journal of cancer (1990), 2017-06, Vol.78, p.37-44

2017

Volltextzugriff (PDF)

predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer

Breast cancer research and treatment, 2010-04, Vol.120 (3), p.655-661

2010

Volltextzugriff (PDF)

BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer

Breast cancer research : BCR, 2020-07, Vol.22 (1), p.79-79, Article 79

2020

Volltextzugriff (PDF)

PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients

Breast cancer research : BCR, 2014-01, Vol.16 (1), p.R13-R13, Article R13

2014

Volltextzugriff (PDF)

FER regulates endosomal recycling and is a predictor for adjuvant taxane benefit in breast cancer

Cell reports (Cambridge), 2022-04, Vol.39 (1), p.110584-110584, Article 110584

2022

Volltextzugriff (PDF)

FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome

Molecular oncology, 2018-11, Vol.12 (11), p.1884-1894

2018

Volltextzugriff (PDF)

Immune landscape of breast tumors with low and intermediate estrogen receptor expression

NPJ breast cancer, 2023-05, Vol.9 (1), p.39-39, Article 39

2023

Volltextzugriff (PDF)

Microarray-Based Determination of Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Status in Breast Cancer

Clinical cancer research, 2009-11, Vol.15 (22), p.7003-7011

2009

Volltextzugriff (PDF)

Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA

Genome medicine, 2019-01, Vol.11 (1), p.1-1, Article 1

2019

Volltextzugriff (PDF)

Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial

The lancet oncology, 2018-12, Vol.19 (12), p.1630-1640

2018

Volltextzugriff (PDF)

Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy

Cancer reports, 2022-02, Vol.5 (2), p.e1470-n/a

2022

Volltextzugriff (PDF)

Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01)

Breast care (Basel, Switzerland), 2021-12, Vol.16 (6), p.598-606

2021

Volltextzugriff (PDF)

1 – 25 von 193

Suche als RSS-Feed

Aktive Filter

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(172)

Publikationsform

Artikel
(193)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study

Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017

Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes

Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging

Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy?

High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: a discrete choice experiment among healthcare providers

Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial

Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen

Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model

Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer

Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years

predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer

BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer

PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients

FER regulates endosomal recycling and is a predictor for adjuvant taxane benefit in breast cancer

FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome

Immune landscape of breast tumors with low and intermediate estrogen receptor expression

Microarray-Based Determination of Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Status in Breast Cancer

Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease

Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA

PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial

Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial

Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy

Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01)

Aktive Filter

Suchergebnisse filtern